Literature DB >> 3157577

Treatment of essential hypertension: changes in blood pressure, echocardiography and electrocardiography on three therapeutic regimes.

G I Russell, J E Pohl, J Baldwin, R F Bing, A M Heagerty, H Thurston, J D Swales.   

Abstract

Forty-three patients with essential hypertension were randomly allocated to one of the following treatment regimes; - atenolol, atenolol and hydralazine or methyl dopa. Blood pressure fell into the normal range at 3 months and was similar in all 3 groups. Blood pressure remained controlled over the period of study. M-mode echocardiography was assessed initially, at 3, 6 and 12 months. All groups showed a fall in the measured indices towards the normal range with a significant reduction in left ventricular wall thickness at 3 months in the methyl dopa group and left ventricular mass in the atenolol group alone of 6 months. In conclusion, no one treatment regime appeared to have sustained advantages over another and none of the groups showed any deterioration on echocardiographic criteria during the study.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3157577     DOI: 10.1007/bf00609677

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  13 in total

1.  ELECTROCARDIOGRAPHIC MANIFESTATIONS OF VENTRICULAR HYPERTROPHY; A COMPUTER STUDY OF ECG-ANATOMIC CORRELATIONS IN 319 CASES.

Authors:  W A CARTER; E H ESTES
Journal:  Am Heart J       Date:  1964-08       Impact factor: 4.749

2.  Letter: Nonobstructive IHSS.

Authors:  J M Criley; A H Blaufuss; A S Abbasi
Journal:  Circulation       Date:  1975-11       Impact factor: 29.690

3.  Cardiac hypertrophy in spontaneously hypertensive rats.

Authors:  S Sen; R C Tarazi; P A Khairallah; F M Bumpus
Journal:  Circ Res       Date:  1974-11       Impact factor: 17.367

4.  Measurement of left ventricular wall thickness and mass by echocardiography.

Authors:  B L Troy; J Pombo; C E Rackley
Journal:  Circulation       Date:  1972-03       Impact factor: 29.690

5.  Ultrasound measurements of the left ventricle. A correlative study with angiocardiography.

Authors:  H Feigenbaum; R L Popp; S B Wolfe; B L Troy; J F Pombo; C L Haine; H T Dodge
Journal:  Arch Intern Med       Date:  1972-03

6.  Regression of left ventricular hypertrophy during treatment with antihypertensive agents.

Authors:  L S Hill; M Monaghan; P J Richardson
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

7.  Echographic determination of left ventricular volumes in pediatric patients.

Authors:  R A Meyer; J Stockert; S Kaplan
Journal:  Circulation       Date:  1975-02       Impact factor: 29.690

8.  Reversal of left ventricular hypertrophy in hypertensive patients treated with methyldopa. Lack of association with blood pressure control.

Authors:  F M Fouad; Y Nakashima; R C Tarazi; E E Salcedo
Journal:  Am J Cardiol       Date:  1982-03       Impact factor: 2.778

9.  Reproducibility of echocardiography. A study evaluating the variability of serial echocardiographic measurements.

Authors:  D A Pietro; A G Voelkel; B J Ray; A F Parisi
Journal:  Chest       Date:  1981-01       Impact factor: 9.410

10.  Cardiac hypertrophy and antihypertensive therapy.

Authors:  S Sen; R C Tarazi; F M Bumpus
Journal:  Cardiovasc Res       Date:  1977-09       Impact factor: 10.787

View more
  1 in total

Review 1.  Atenolol. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders.

Authors:  A N Wadworth; D Murdoch; R N Brogden
Journal:  Drugs       Date:  1991-09       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.